[1]
|
Klareskog, L., Catrina, A.I. and Paget, S. (2009) Rheumatoid Arthritis. Lancet, 373, 659-672. http://dx.doi.org/10.1016/S0140-6736(09)60008-8
|
[2]
|
Scott, D.L., Wolfe, F. and Huizinga, T.W. (2010) Rheumatoid Arthritis. Lancet, 376, 1094-1108. http://dx.doi.org/10.1016/S0140-6736(10)60826-4
|
[3]
|
Cutler, C.W., Kalmar, J.R. and Genco, C.A. (1995) Pathogenic Strategies of the Oral Anaerobe, Porphyromonas gingivalis. Trends Microbiol, 3, 45-51. http://dx.doi.org/10.1016/S0966-842X(00)88874-5
|
[4]
|
de Pablo, P., Dietrich, T. and McAlindon, T.E. (2008) Association of Periodontal Disease and Tooth Loss with Rheumatoid Arthritis in the US Population. The Journal of Rheumatology, 35, 70-76.
|
[5]
|
Pischon, N., Pischon, T., Kroger, J., Gülmez, E., Kleber, B.M., Bernimoulin, J.P., et al. (2008) Association among Rheumatoid Arthritis, Oral Hygiene, and Periodontitis. Journal of Periodontology, 79, 979-986. http://dx.doi.org/10.1902/jop.2008.070501
|
[6]
|
Dissick, A., Redman, R.S., Jones, M., Rangan, B.V., Reimold, A., Griffiths, G.R., et al. (2010) Association of Periodontitis with Rheumatoid Arthritis: A Pilot Study. Journal of Periodontology, 81, 223-230. http://dx.doi.org/10.1902/jop.2009.090309
|
[7]
|
Ogrendik, M. (2009) Rheumatoid Arthritis Is Linked to Oral Bacteria: Etiological Association. Modern Rheumatology, 19, 453-456. http://dx.doi.org/10.3109/s10165-009-0194-9
|
[8]
|
Marotte, H., Farge, P., Gaudin, P., Alexandre, C., Mougin, B. and Miossec, P. (2006) The Association between Periodontal Disease and Joint Destruction in Rheumatoid Arthritis Extends the Link between the HLA-DR Shared Epitope and Severity of Bone Destruction. Annals of the Rheumatic Diseases, 65, 905-909. http://dx.doi.org/10.1136/ard.2005.036913
|
[9]
|
De Smit, M., Westra, J., Vissink, A., Van der Meer, B.D., Brouwer, E. and van Winkelhoff, A.J. (2012) Periodontitis in Established Rheumatoid Arthritis Patients: A Cross-Sectional Clinical, Microbiological and Serological Study. Arthritis Research & Therapy, 14, R222. http://dx.doi.org/10.1186/ar4061
|
[10]
|
Al-Katma, M.K., Bissada, N.F., Bordeaux, J.M., Sue, J. and Askari, A.D. (2007) Control of Periodontal Infection Reduces the Severity of Active Rheumatoid Arthritis. Journal of Clinical Rheumatology, 13, 134-137. http://dx.doi.org/10.1097/RHU.0b013e3180690616
|
[11]
|
Ribeiro, J., Leao, A. and Novaes, A.B. (2005) Periodontal Infection as a Possibleseverity Factor for Rheumatoid Arthritis. Journal of Clinical Periodontology, 32, 412-416. http://dx.doi.org/10.1111/j.1600-051X.2005.00689.x
|
[12]
|
Ortiz, P., Bissada, N.F., Palomo, L., Han, Y.W., Al-Zahrani, M.S., Panneerselvam, A. and Askari, A. (2009) Periodontal Therapy Reduces the Severity of Active Rheumatoid Arthritis in Patients Treated with or without Tumor Necrosis Factor Inhibitors. Journal of Periodontology, 80, 535-540. http://dx.doi.org/10.1902/jop.2009.080447
|
[13]
|
Marsh, P.D. and Martin, M.V. (2001) Oral Microbiology. 4th Edition, MPG Books Ltd., Bodmin.
|
[14]
|
Hajishengallis, G., Wang, M., Harokopakis, E., Triantafilou, M. and Triantafilou, K. (2006) Porphyromonas gingivalis Fimbriae Proactively Modulate Beta2 Integrin Adhesive Activity and Promote Binding to and Internalization by Macrophages. Infection and Immunity, 74, 5658-5666. http://dx.doi.org/10.1128/IAI.00784-06
|
[15]
|
Kido, J., Kido, R., Suryono, Kataoka, M., Fagerhol, M.K. and Nagata, T. (2003) Calprotectin Release from Human Neutrophils Is Induced by Porphyromonas gingivalis Lipopolysaccharide via the CD-14-Toll-Like Receptor-Nuclear Factor KappaB Pathway. Journal of Periodontal Research, 38, 557-563.
|
[16]
|
Vossenaar, E.R. and Robinson, W.H. (2005) Citrullination and Autoimmune Disease: 8th Bertine Koperberg Meeting. Annals of the Rheumatic Diseases, 64, 1513-1515. http://dx.doi.org/10.1136/ard.2005.045716
|
[17]
|
Coenen, D., Verschueren, P., Westhovens, R. and Bossuyt, X. (2007) Technical and Diagnostic Performance of 6 Assays for the Measurement of Citrullinated Protein/Peptide Antibodies in the Diagnosis of Rheumatoid Arthritis. Clinical Chemistry, 53, 498-504. http://dx.doi.org/10.1373/clinchem.2006.078063
|
[18]
|
Nicaise Roland, P., Grootenboer Mignot, S., Bruns, A., Hurtado, M., Palazzo, E., Hayem, G., et al. (2008) Antibodies to Mutated Citrullinated Vimentin for Diagnosing Rheumatoid Arthritis in Anti-CCP-Negative Patients and for Monitoring Infliximab Therapy. Arthritis Research & Therapy, 10, R142. http://dx.doi.org/10.1186/ar2570
|
[19]
|
Ogrendik, M., Kokino, S., Ozdemir, F., Bird, P.S. and Hamlet, S. (2005) Serum Antibodies to Oral Anaerobic Bacteria in Patients with Rheumatoid Arthritis. Medscape General Medicine, 7, 2.
|
[20]
|
Chen, H.H., Chen, D.Y., Lai, K.L., Chen, Y.M., Chou, Y.J., Chou, P., et al. (2013) Periodontitis and Etanercept Discontinuation Risk in Anti-Tumor Necrosis Factor-Naive Rheumatoid Arthritis Patients: A Nationwide Population-Based Cohort Study. Journal of Clinical Rheumatology, 19, 432-438. http://dx.doi.org/10.1097/RHU.0000000000000041
|
[21]
|
Kinloch, A., Tatzer, V., Wait, R., Peston, D., Lundberg, K., Donatien, P., et al. (2005) Identification of Citrullinated Alpha-Enolase as a Candidate Autoantigen in Rheumatoid Arthritis. Arthritis Research & Therapy, 7, R1421-1429. http://dx.doi.org/10.1186/ar1845
|
[22]
|
Wegner, N., Wait, R., Sroka, A., Eick, S., Nguyen, K.A., Lundberg, K., et al. (2010) Peptidylarginine Deiminase from Porphyromonas gingivalis Citrullinates Human Fibrinogen and α-Enolase: Implications for Autoimmunity in Rheumatoid Arthritis. Arthritis Rheumatology, 62, 2662-2672. http://dx.doi.org/10.1002/art.27552
|
[23]
|
Hitchon, C.A., Chandad, F., Ferucci, E.D., Willemze, A., Ioan-Facsinay, A., van der Woude, D., et al. (2010) Antibodies to Porphyromonas gingivalis Are Associated with Anticitrullinated Protein Antibodies in Patients with Rheumatoid Arthritis and Their Relatives. Journal of Rheumatology, 37, 1105-1112. http://dx.doi.org/10.3899/jrheum.091323
|
[24]
|
Okada, M., Kobayashi, T., Ito, S., Yokoyama, T., Komatsu, Y., Abe, A., et al. (2011) Antibody Responses to Periodontopathic Bacteria in Relation to Rheumatoid Arthritis in Japanese Adults. Journal of Periodontology, 82, 1433-1441. http://dx.doi.org/10.1902/jop.2011.110020
|
[25]
|
Mikuls, T.R., Thiele, G.M., Deane, K.D., Payne, J.B., O’Dell, J.R., Yu, F., et al. (2012) Porphyromonas gingivalis and Disease-Related Autoantibodies in Individuals at Increased Risk of Rheumatoid Arthritis. Arthritis Rheumatology, 64, 3522-3530. http://dx.doi.org/10.1002/art.34595
|
[26]
|
Mikuls, T.R., Payne, J.B., Reinhardt, R.A., Thiele, G.M., Maziarz, E., Cannella, A.C., et al. (2009) Antibody Responses to Porphyromonas gingivalis (P. gingivalis) in Subjects with Rheumatoid Arthritis and Periodontitis. International Immunopharmacology, 9, 38-42. http://dx.doi.org/10.1016/j.intimp.2008.09.008
|
[27]
|
Moen, K., Brun, J.G., Valen, M., Skartveit, L., Eribe, E.K., Olsen, I., et al. (2006) Synovial Inflammation in Active Rheumatoid Arthritis and Psoriatic Arthritis Facilitates Trapping of a Variety of Oral Bacterial DNAs. Clinical and Experimental Rheumatology, 24, 656-663.
|
[28]
|
Martinez-Martinez, R.E., Abud-Mendoza, C., Patino-Marin, N., Rizo-Rodríguez, J.C., Little, J.W. and Loyola-Rodríguez, J.P. (2009) Detection of Periodontal Bacterial DNA in Serum and Synovial Fluid in Refractory Rheumatoid Arthritis Patients. Journal of Clinical Periodontology, 36, 1004-1010. http://dx.doi.org/10.1111/j.1600-051X.2009.01496.x
|
[29]
|
Kinane, D.F., Riggio, M.P., Walker, K.F., MacKenzie, D. and Shearer, B. (2005) Bacteraemia Following Periodontal Procedures. Journal of Clinical Periodontology, 32, 708-713. http://dx.doi.org/10.1111/j.1600-051X.2005.00741.x
|
[30]
|
Bartold, P.M., Marino, V., Cantley, M. and Haynes, D.R. (2010) Effect of Porphyromonas gingivalis-Induced Inflammation on the Development of Rheumatoid Arthritis. Journal of Clinical Periodontology, 37, 405-411. http://dx.doi.org/10.1111/j.1600-051X.2010.01552.x
|
[31]
|
Cantley, M.D., Haynes, D.R., Marino, V. and Bartold, P.M. (2011) Pre-Existing Periodontitis Exacerbates Experi- mental Arthritis in a Mouse Model. Journal of Clinical Periodontology, 38, 532-541. http://dx.doi.org/10.1111/j.1600-051X.2011.01714.x
|
[32]
|
Kinloch, A.J., Alzabin, S., Brintnell, W., Wilson, E., Barra, L., Wegner, N., et al. (2011) Immunization with Porphyromonas gingivalis Enolase Induces Autoimmunity to Mammalian α-Enolase and Arthritis in DR4-IE-Transgenic Mice. Arthritis Rheumatology, 63, 3818-3823. http://dx.doi.org/10.1002/art.30639
|
[33]
|
Mahdi, H., Fisher, B.A., Kallberg, H., Plant, D., Malmstrom, V., Ronnelid, J., et al. (2009) Specific Interaction between Genotype, Smoking, and Autoimmunity to Citrullinated Alpha-Enolase in the Etiology of Rheumatoid Arthritis. Nature Genetics, 41, 1319-1324. http://dx.doi.org/10.1038/ng.480
|
[34]
|
Maresz, K.J., Hellvard, A., Sroka, A., Adamowicz, K., Bielecka, E., Koziel, J., et al. (2013) Porphyromonas gingivalis Facilitates the Development and Progression of Destructive Arthritis through Its Unique Bacterial Peptidylarginine Deiminase (PAD). Public Library of Science Pathog, 9, e1003627. http://dx.doi.org/10.1371/journal.ppat.1003627
|
[35]
|
Svartz, N. (1948) The Treatment of Rheumatic Polyarthritis with Acid Azo Compounds. Rheumatism, 4, 180-185.
|
[36]
|
McConke, B., Amos, R.S., Durham, S., Forster, P.J., Hubball, S. and Walsh, L. (1980) Sulphasalazine in Rheumatoid Arthritis. British Medical Journal, 280, 442-444. http://dx.doi.org/10.1136/bmj.280.6212.442
|
[37]
|
Hoult, J.R. (1986) Pharmacological and Biochemical Actions of Sulphasalazine. Drugs, 32, 18-26. http://dx.doi.org/10.2165/00003495-198600321-00005
|
[38]
|
Pullar, T., Hunter, J.A. and Capell, H.A. (1985) Which Component of Sulphasalazine Is Active in Rheumatoid Arthritis? British Medical Journal (Clinical Research Education), 290, 1535-1538. http://dx.doi.org/10.1136/bmj.290.6481.1535
|
[39]
|
Ash, G., Baker, R., Rajapakse, C. and Swinson, D.R. (1986) Study of Sulphamethoxazole in Rheumatoid Arthritis. British Journal of Rheumatology, 25, 285-287. http://dx.doi.org/10.1093/rheumatology/25.3.285
|
[40]
|
Ostrander, F.D. (1948) Vitamins, Sulfonamides and Antibiotics in Periodontal Therapy. Journal of the American Dental Association, 37, 279-288.
|
[41]
|
Felson, D.T., Anderson, J.J. and Meenan, R.F. (1992) Use of Short-Term Efficacy/Toxicity Tradeoffs to Select Second-Line Drugs in Rheumatoid Arthritis. A Metaanalysis of Published Clinical Trials. Arthritis Rheumatology, 35, 1117-1125. http://dx.doi.org/10.1002/art.1780351003
|
[42]
|
Weinblatt, M.E., Reda, D., Henderson, W., et al. (1999) Sulfasalazine Treatment for Rheumatoid Arthritis: A Metaanalysis of 15 Randomized Trials. Journal of Rheumatology, 26, 2123-2130.
|
[43]
|
Garrido-Mesa, N., Zarzuelo, A. and Gálvez, J. (2013) Minocycline: Far beyond an Antibiotic. British Journal of Pharmacology, 169, 337-352. http://dx.doi.org/10.1111/bph.12139
|
[44]
|
Kloppenburg, M., Breedveld, F.C., Terwiel, J.P., Mallee, C. and Dijkmans, B.A. (1994) Minocycline in Active Rheumatoid Arthritis. A Double-Blind, Placebo-Controlled Trial. Arthritis Rheumatology, 37, 629-636. http://dx.doi.org/10.1002/art.1780370505
|
[45]
|
Tilley, B.C., Alarcón, G.S., Heyse, S.P., et al., MIRA Trial Group (1995) Minocycline in Rheumatoid Arthritis. A 48-Week, Double-Blind, Placebo-Controlled Trial. Annals of International Medicine, 122, 81-89. http://dx.doi.org/10.7326/0003-4819-122-2-199501150-00001
|
[46]
|
Langevitz, P. Livneh, A., Bank, I. and Pras, M. (2000) Benefits and Risks of Minocycline in Rheumatoid Arthritis. Drug Safety, 22, 405-414. http://dx.doi.org/10.2165/00002018-200022050-00007
|
[47]
|
Stone, M. Fortin, P.R., Pacheco-Tena, C. and Inman, R.D. (2003) Should Tetracycline Treatment Be Used More Extensively for Rheumatoid Arthritis? Metaanalysis Demonstrates Clinical Benefit with Reduction in Disease Activity. Journal of Rheumatology, 30, 2112-2122.
|
[48]
|
Kwiatkowska, B. and Maslińska, M. (2012) Macrolide Therapy in Chronic Inflammatory Diseases. Mediators of Inflammation, 2012, Article ID: 636157. http://dx.doi.org/10.1155/2012/636157
|
[49]
|
Saviola, G., Abdi Ali, L., Rossini, P., et al. (2002) Clarithromycin in Rheumatoid Arthritis Patients Not Responsive to Disease-Modifying Antirheumatic Drugs: An Open, Uncontrolled Pilot Study. Clinical and Experimental Rheumatology, 20, 373-378.
|
[50]
|
Saviola, G., Abdi-Ali, L., , L., et al. (2013) Clarithromycin in Rheumatoid Arthritis: The Addition to Methotrexate and Low-Dose Methylprednisolone Induces a Significant Additive Value—A 24-Month Single-Blind Pilot Study. Rheumatology International, 33, 2833-2838. http://dx.doi.org/10.1007/s00296-013-2822-0
|
[51]
|
Ogrendik, M. (2007) Effects of Clarithromycin in Patients with Active Rheumatoid Arthritis. Current Medicine Research and Opinion, 23, 515-522. http://dx.doi.org/10.1185/030079906X167642
|
[52]
|
Ogrendik, M. (2009) Efficacy of Roxithromycin in Adult Patients with Rheumatoid Arthritis Who Had Not Received Disease-Modifying Antirheumatic Drugs: A 3-Month, Randomized, Double-Blind, Placebo-Controlled Trial. Clinical Therapeutics, 31, 1754-1764. http://dx.doi.org/10.1016/j.clinthera.2009.08.014
|
[53]
|
Ogrendik, M. and Karagoz, N. (2011) Treatment of Rheumatoid Arthritis with Roxithromycin: A Randomized Trial. Postgraduate Medicine, 123, 220-227. http://dx.doi.org/10.3810/pgm.2011.09.2478
|